Vol 12, No 7 (July 31, 2023) - Translational Lung Cancer Research

Editorial

Targeting gene fusions in non-small cell lung cancer—a ceaseless success story?

Per Hydbring

PDF Pages: 1358-1360 Full Text (639) COI Form Open Access

Low level ALK FISH positive results should be approached with caution and confirmed by an orthogonal method

Gokce A. Toruner

PDF Pages: 1361-1363 Full Text (1108) COI Form Open Access

Tackling the challenge of brain involvement in driver-negative non-small cell lung cancer

Petros Christopoulos

PDF Pages: 1364-1368 Full Text (878) COI Form Open Access

Neoadjuvant immunochemotherapy in resectable non-small cell lung cancer: the more cycles, the better?

Ezgi B. Ulas, Idris Bahce

PDF Pages: 1369-1371 Full Text (1023) COI Form Open Access

Original Article

Radiomic signature accurately predicts the risk of metastatic dissemination in late-stage non-small cell lung cancer

Agata Małgorzata Wilk, Emilia Kozłowska, Damian Borys, Andrea D’Amico, Krzysztof Fujarewicz, Izabela Gorczewska, Iwona Debosz-Suwinska, Rafał Suwinski, Jarosław Smieja, Andrzej Swierniak

PDF Pages: 1372-1383 Full Text (1350) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Does hyperthermic povidone-iodine lavage increase the apoptotic rate of residual cancer cell in patients with malignant pleural mesothelioma?—a prospective pilot study

Andrea Bille, Hiral Jhala, Leanne Ashrafian, Leanne Allison, Matthew Russell, Roland Fleck, Daisuke Nonaka

PDF Pages: 1384-1390 Full Text (1558) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Patient-reported impact of symptoms in lung cancer (PRISM-LC)

Anika Varma, Jennifer Weinstein, Jamison Seabury, Spencer Rosero, Christine Zizzi, Nuran Dilek, John Heatwole, Megan Baumgart, Deborah Mulford, Ronald Maggiore, Lainie Conrow, Jennifer C. King, Jacinta Wiens, Chad Heatwole

PDF Pages: 1391-1413 Full Text (1250) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Monitoring with circulating tumor cells in the perioperative setting of patients with surgically treated stages I–IIIA NSCLC

Yago Garitaonaindia, Ramón Aguado-Noya, Aranzazu Garcia-Grande, Mar Cordoba, Maria Jose Coronado Albi, Jose Luis Campo Cañaveral, Virginia Calvo, Mariola Blanco Clemente, Ruth Álvarez, Marta Peñas, Luis Chara, Ana Royuela, Mariano Provencio

PDF Pages: 1414-1424 Full Text (1476) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

A prospective phase 2 study of expeditious EGFR genotyping and immediate therapeutic initiation through extracellular vesicles (EV)-based bronchoalveolar lavage fluid (BALF) liquid biopsy in advanced NSCLC patients

In Ae Kim, Jae Young Hur, Hee Joung Kim, Wan Seop Kim, Kye Young Lee

PDF Pages: 1425-1435 Full Text (1214) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Distinct metastatic spread and progression patterns in patients treated with crizotinib for ROS1- and ALK-rearranged non-small cell lung cancer: a single-center retrospective study

Tomoaki Nakamura, Tatsuya Yoshida, Yuki Takeyasu, Ken Masuda, Yuki Sinno, Yuji Matsumoto, Yusuke Okuma, Yasushi Goto, Hidehito Horinouchi, Noboru Yamamoto, Yuichiro Ohe

PDF Pages: 1436-1444 Full Text (1416) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Detection of resistance mutations in patients with anaplastic lymphoma kinase-rearranged lung cancer through liquid biopsy

Takaaki Sasaki, Ryohei Yoshida, Kiichi Nitanai, Takashi Watanabe, Toshiyuki Tenma, Ryotaro Kida, Chie Mori, Yasuhiro Umekage, Noriko Hirai, Yoshinori Minami, Shunsuke Okumura

PDF Pages: 1445-1453 Full Text (1157) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

First-line osimertinib for patients with EGFR-mutated advanced non-small cell lung cancer: efficacy and safety during the COVID-19 pandemic

Suganija Lakkunarajah, Pauline T. Truong, Jeffrey N. Bone, Curtis Hughesman, Stephen Yip, Deepu Alex, Jason Hart, Philip Pollock, Sarah Egli, Melissa Clarkson, Mary Lesperance, Doran Ksienski

PDF Pages: 1454-1465 Full Text (2160) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Learning curve for uniportal thoracoscopic pulmonary segmentectomy: how many procedures are required to acquire expertise?

Natsumi Matsuura, Hitoshi Igai, Fumi Ohsawa, Kazuki Numajiri, Mitsuhiro Kamiyoshihara

PDF Pages: 1466-1476 Full Text (625) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Identification of lysosomal genes associated with prognosis in lung adenocarcinoma

Houqiang Li, Xinyu Sha, Wenmiao Wang, Zhanghao Huang, Peng Zhang, Lei Liu, Silin Wang, Youlang Zhou, Shuai He, Jiahai Shi

PDF Pages: 1477-1495 Full Text (2114) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Diagnostic accuracy and safety of electromagnetic navigation transthoracic needle biopsy under moderate sedation for the diagnosis of peripheral pulmonary lesions

SoJeong Kim, NaYoung Kim, SooJie Chung, JungHyun Kim, InGyu Hyun, JeongHee Choi, HeeSung Lee

PDF Pages: 1496-1505 Full Text (966) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Prognostic value of baseline and early treatment response of neutrophil-lymphocyte ratio, C-reactive protein, and lactate dehydrogenase in non-small cell lung cancer patients undergoing immunotherapy

MinDong Sung, Won Seok Jang, Hae Reong Kim, Ji Ae Park, Sun Min Lim, Hye Ryun Kim, Byoung Chul Cho, Yu Rang Park, Min Hee Hong

PDF Pages: 1506-1516 Full Text (1352) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Overexpression of MRPL19 in predicting poor prognosis and promoting the development of lung adenocarcinoma

Dong Wei, Daqiang Sun, Rafael Sirera, Muhammad Zubair Afzal, Tracy L. Leong, Xin Li, Yuhang Wang

PDF Pages: 1517-1538 Full Text (1401) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Risk factors for pulmonary embolism in lung cancer patients with lower limb deep venous thrombosis: a case-control study

Hai-Yang Dong, Min-Si Tong, Juan Wang, Yuan Liu, Guang-Yu Tao, René Horsleben Petersen, Luis Jara-Palomares, Yi Wang, Yan-Bing Sun, Jie Chen

PDF Pages: 1539-1548 Full Text (1544) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Review Article

A narrative review of methods for the identification of ALK fusions in patients with non-small cell lung carcinoma

Susana Hernandez, Esther Conde, Marta Alonso, Adrian Illarramendi, Helena Bote de Cabo, Jon Zugazagoitia, Luis Paz-Ares, Fernando Lopez-Rios

PDF Pages: 1549-1562 Full Text (3038) Reporting Checklist Peer Review File COI Form Open Access

Advancements of ALK inhibition of non-small cell lung cancer: a literature review

Victor Zia, Csongor György Lengyel, Carla Chizuru Tajima, Ramon Andrade de Mello

PDF Pages: 1563-1574 Full Text (2814) Reporting Checklist COI Form Open Access

Review of the use of radiomics to assess the risk of recurrence in early-stage non-small cell lung cancer

William Adam Libling, Ronald Korn, Glen J. Weiss

PDF Pages: 1575-1589 Full Text (1839) Reporting Checklist Peer Review File COI Form Open Access

EGFR exon 20 insertion mutations and ERBB2 mutations in lung cancer: a narrative review on approved targeted therapies from oral kinase inhibitors to antibody-drug conjugates

Daniel Sentana-Lledo, Emmeline Academia, Hollis Viray, Deepa Rangachari, Susumu S. Kobayashi, Paul A. VanderLaan, Daniel B. Costa

PDF Pages: 1590-1610 Full Text (6359) Reporting Checklist Peer Review File COI Form Open Access

Case Report

Multiple bronchiolar adenomas/ciliated muconodular papillary tumors of the bilateral lung with tumor budding and potential malignant transformation into squamous cell carcinoma: a case report and literature review

Jiaen Sun, Weidi Zhao, Chong Zhang, Enkuo Zheng, Xu Jiang, Li Wang, Takuo Hayashi, Eiichi Sasaki, Mitsuhiro Tachibana, Guofang Zhao

PDF Pages: 1611-1624 Full Text (1793) Reporting Checklist Peer Review File COI Form Open Access

Selpercatinib in patients with RET fusion positive non-small cell lung cancer: updated follow-up of the LIBRETTO-001 phase I/II trial

Thomas E. Stinchcombe

PDF Pages: 1655-1657 Full Text (989) Peer Review File COI Form Open Access

Vol 12, No 7 (July 31, 2023): Translational Lung Cancer Research